ロード中...
Subcutaneous Abatacept in Patients With Polyarticular‐Course Juvenile Idiopathic Arthritis: Results From a Phase III Open‐Label Study
OBJECTIVE: To investigate the pharmacokinetics, effectiveness, and safety of subcutaneous (SC) abatacept treatment over 24 months in patients with polyarticular‐course juvenile idiopathic arthritis (JIA). METHODS: In this phase III, open‐label, international, multicenter, single‐arm study, patients...
保存先:
| 出版年: | Arthritis Rheumatol |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2018
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6032847/ https://ncbi.nlm.nih.gov/pubmed/29481737 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.40466 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|